arrow
W

Weiying Gu

Changzhou Medical Center
H指数:14
被引数:572

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ruxolitinib improves hematopoietic regeneration by restoring mesenchymal stromal cell function in acute graft-versus-host disease (vol 135, e200847, 2025)

鲁索利替尼通过恢复间充质基质细胞功能改善急性移植物抗宿主病中的造血再生(vol 135, e200847, 2025)

2025-11-171
PRE
Endothelial Activation and Stress Index Serves as a Predictor for Survival in Lymphoma-Associated Hemophagocytic Lymphohistiocytosis: A Retrospective Multicenter Cohort Study of Jiangsu Cooperative Lymphoma Group

内皮激活和应激指数作为淋巴瘤相关性噬血细胞性淋巴组织细胞增多症的生存预测因子:一项江苏省淋巴瘤协作组的多中心回顾性队列研究

2025-09-080
PRE
Clinical outcomes and microenvironment profiling in relapsed/refractory multiple myeloma patients with extramedullary disease receiving anti-BCMA CAR T-cell-based therapy
2024-08-280
OAAI
Improved prevention and treatment strategies for differentiation syndrome contribute to reducing early mortality in patients with acute promyelocytic leukemia
2024-07-150
OAAI
Multi-center study of COVID-19 infection in elderly patients with lymphoma: on behalf of Jiangsu Cooperative Lymphoma Group (JCLG)
2024-04-220
PRE
Bispecific CAR T cell therapy targeting BCMA and CD19 in relapsed/refractory multiple myeloma: a phase I/II trial

靶向BCMA和CD19的双特异性CAR T细胞治疗复发/难治性多发性骨髓瘤: I/II期试验

2024-04-2011
OAAI
The clinical significance and prognostic value of serum beta-2 microglobulin in adult lymphoma-associated hemophagocytic lymphohistiocytosis: a multicenter analysis of 326 patients
2024-01-250
PRE
Ruxolitinib improves hematopoietic regeneration by restoring mesenchymal stromal cell function in acute graft-versus-host disease

鲁索替尼通过恢复间充质基质细胞功能改善急性移植物抗宿主病中的造血再生

2023-08-013
OAAI